News
08/22/2022
Pharos Capital Sells TechLab, Inc. to SSI Diagnostica
Pharos Capital Group, LLC (“Pharos”), a private equity firm based in Dallas and Nashville, announced it has sold its stake in portfolio company TechLab, Inc. (“TechLab”), a leading developer and manufacturer of rapid, non-invasive diagnostic tests for infectious disease, intestinal inflammation, and parasitology, to SSI Diagnostica, a portfolio company of the private investment firm Adelis …
08/15/2022
ivWatch Extends Its Global Reach Signing Three New Distribution Partners
Newport News, VA, ivWatch, LLC, an innovative IV safety company working to eliminate harm caused by infiltration and extravasation events, announced three new strategic distribution partnerships internationally. Bameco in Austria, Warba Medical Supplies in Kuwait, and Mustafa Sultan Science & Industry Co, LLC in Oman have each signed exclusive agreements to promote, sell, and support …
08/15/2022
Registration Now Open for Catalyst Life Sciences Conference
The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), announced that registration is open for the Catalyst Life Sciences Conference. The event will be held October 6-7, 2022 at the Omni Hotel in Richmond, Virginia. This conference is designed for scientists, engineers, entrepreneurs, incubators and biohubs, life science companies, technology transfer …
08/13/2022
Kaléo launches government biz unit
Richmond pharma company also hires chief commercial officer. Richmond-based Kaléo on Thursday announced the formation of a new government business unit to focus on domestic and international procurement of the company’s system to reverse the effect of weaponized opioids as well as to provide access to it for military and civilian stockpiles. Kaléo’s Rapid …
08/10/2022
HemoShear Develops New Human Tissue-Based Model of Rare Liver Disease Under Research Collaboration with Takeda
Charlottesville, VA – HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, has received a milestone payment under its October 2020 research collaboration and service agreement with Takeda. The milestone acknowledges development of a human tissue-based model of an undisclosed rare liver disease using the company’s REVEAL-Tx™ platform. REVEAL-Tx™ combines physiological and computational models of …
08/09/2022
The trust-builder: a cancer center director’s try-it-all strategy for breaking the barriers between research and Black patients
RICHMOND, Va. — The residents agreed: Nobody like Robert Winn — director of the Virginia Commonwealth University Massey Cancer Center — had ever visited the neighborhood before. This development on the outskirts of Richmond, more parking spots and asphalt than trees and lawn, was “the hood,” after all, they said. “This neighborhood — it’s been …
08/03/2022
Kaléo Enters Into Licensing Agreement With Valeo Pharma For The Canadian Rights to ALLERJECT®(epinephrine injection, USP)
Richmond, Va – Kaléo, a privately held U.S. pharmaceutical company, today announced that it has entered into a ten-year License, Supply, and Commercialization agreement with Valeo Pharma, a Canadian pharmaceutical company, for the Canadian rights to ALLERJECT® (epinephrine injection, USP) for the treatment of severe allergic reactions. “Patients with life threatening allergies across Canada deserve access to this …
07/28/2022
Virginia Bio and Virginia Bio Connect honored as “Top Employers for Interns” in Virginia!
RICHMOND – The Virginia Talent + Opportunity Partnership (V-TOP), in collaboration with the State Council of Higher Education for Virginia (SCHEV) and the Virginia Chamber of Commerce, recognized 32 recipients of the inaugural 2022 Top Virginia Employers for Interns Awards today. The virtual recognition event included video remarks from SCHEV Director, Peter Blake, Virginia Chamber …
07/21/2022
Bristol Myers Squibb Launches Disability Diversity in Clinical Trials (DDiCT) Initiative to Improve Healthcare Outcomes for People with Disabilities
PRINCETON, N.J.–(BUSINESS WIRE)– Bristol Myers Squibb (NYSE:BMY) today announced, in collaboration with Disability Solutions, a U.S.- based non-profit organization that supports companies globally to achieve true disability inclusion, the launch of the Disability Diversity in Clinical Trials (DDiCT) initiative. This new initiative aligns with Bristol Myers Squibb’s broader inclusion and diversity health equity commitments to address health disparities, clinical trial diversity, …
07/19/2022
Canon Medical Systems USA Inc. Announces Expansion of Distributorship with the Acquisition of NXC Imaging
Tustin, California, (GLOBE NEWSWIRE) — Canon Medical Systems USA Inc., a commercial subsidiary of Canon Medical Systems Corporation and a global leader in innovative diagnostic imaging technology, today announces it has signed a definitive agreement to acquire NXC Imaging, a medical imaging equipment distributor and service provider headquartered in Minneapolis, Minnesota. Founded in 1964, NXC …
07/06/2022
AMPEL BioSolutions’ Precision Medicine Breakthrough Predicts Drug Options with RNA Analytics & Machine Learning
CHARLOTTESVILLE, Va., July 6, 2022 — AMPEL BioSolutions announced a breakthrough in precision and personalized medicine that could modernize the way doctors treat patients across a wide variety of diseases including autoimmunity, infectious disease and cancer. Revealed at the Precision Medicine World Conference in Silicon Valley California, the first-in-class platform technology utilizes RNA analytics and machine learning to …
07/05/2022
GMU gets $3.75M to grow Virginia’s nanotech industry
George Mason University will launch a new program to catalyze the growth of the nanotechnology industry in Northern Virginia, thanks to $3.75 million in grants. The Fairfax institution is receiving $2.5 million for the initiative through Go Virginia Region 7, the local chapter of the commonwealth-funded initiative led by the Virginia Department of Housing and …
06/29/2022
Bio-plastics startup wins Lighthouse Labs pitch contest
Charlottsville, VA (Virginia Business) – While pitching to the sharks, entrepreneur Alec Brewer told them, “I do have white powder in my pocket,” before quickly clarifying that it wasn’t an illicit substance: “It’s PHB! It’s PHB!” The co-founder and CEO of Charlottesville-based biodegradable plastics manufacturer Ourobio, Brewer explained that his company makes PHB, or polyhydroxybutyrate, …
06/26/2022
USA FDA Grants Fast Track Designation to ReAlta Life Sciences’ Lead Compound RLS-0071
ReAlta Life Sciences (“ReAlta”), Inc., a clinical stage, rare disease company dedicated to harnessing the power of the immune system to address life threatening diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to RLS-0071 for the treatment of hypoxic ischemic encephalopathy (HIE). RLS-0071 is the Company’s lead dual …
06/20/2022
Adial Pharmaceuticals Awarded Additional U.S. Patent Combining the Use of the Company’s Proprietary Genetic Diagnostic With AD04 to Treat Alcohol and Drug Dependence
New patent covers the use of the full genetic panel measuring all five genetic biomarkers CHARLOTTESVILLE, Va., — Adial Pharmaceuticals, Inc. (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced patent number 11,351,154 was issued on June 7, 2022, by …
06/08/2022
AGROSPHERES ANNOUNCES NOVEL MODALITIES PARTNERSHIP WITH BAYER
AgroSpheres’ AgriCell technology will help deliver the next generation of high-performing, environmentally safe crop protection CHARLOTTESVILLE, VA – AgroSpheres, INC., a leader in developing the next generation of environmentally friendly crop protection products, today announced a multi-year collaboration with Bayer to create novel modalities of biologicals for use as crop protection products. “Teaming up with …
06/03/2022
Ourobio takes top honors at Lighthouse Labs Demo Day
Clutching a plush shark, Alec Brewer, the co-founder and CEO of Ourobio, beamed Tuesday from the stage at the Byrd Theatre. The cuddly sea hunter marked his company as winner of a $1,500 cash prize for a “Shark Tank”-style competition at the the Lighthouse Labs Demo Day showcase. “The cash is critical to us right now,” …
06/01/2022
Roanoke labs project awaits final budget approval
The intended site for 30,000 square feet of lab space is a Carilion-owned building on South Jefferson Street. An estimated 30,000 square feet of shared lab space could go online in Roanoke within a year and a half, assuming that the General Assembly votes Wednesday to approve a compromise budget that includes nearly $16 million …
05/31/2022
Embody, Inc. Announces 510(k) Clearances for TAPESTRY® RC for Rotator Cuff Repair
Embody, Inc., a privately-held medical device company focused on soft tissue healing, announced that it has received 510(k) clearances from the Food and Drug Administration (FDA) for its TAPESTRY RC System for the treatment of rotator cuff disease. Uniquely designed for arthroscopic procedures, TAPESTRY RC System combines the healing benefits of the biointegrative collagen TAPESTRY …
05/26/2022
GPB Scientific Announces Initial Availability of Advanced Cell Separation Platform; Name Change to Curate Biosciences
CARLSBAD, Calif., /PRNewswire/ — GPB Scientific, Inc. has launched its go-to-market activities for the transformational Curate® Cell Processing System to streamline the manufacture of cell therapies, making them economically and reliably available to the largest number of patients. The company’s advanced cell separation platform is in evaluations at select biopharmas, contract manufacturers, and academic centers …
05/24/2022
Civica COO Ned McCoy to Serve as Civica’s Next President and CEO
Civica, Inc. announced that Ned McCoy, currently Civica’s Chief Operating Officer, will succeed Martin VanTrieste as Civica’s President and Chief Executive Officer, effective June 1. VanTrieste will remain an advisor to the Company and continue serving on Civica’s Board of Directors. As part of this transition, McCoy will also join the Civica Board of Directors …
05/24/2022
Civica Announces Leadership Transition
Civica Chief Operating Officer Ned McCoy to Serve as Civica’s Next President and Chief Executive Officer. Martin VanTrieste to Retire as CEO; Will Continue Serving on Civica Board of Directors. LEHI, Utah–(BUSINESS WIRE)–Civica, Inc. (Civica, Civica Rx) today announced that Ned McCoy, currently Civica’s Chief Operating Officer, will succeed Martin VanTrieste as Civica’s President and …
05/24/2022
Prestigious annual pediatric medical device competition reveals five finalists
Five finalists have been named in the prestigious annual “Make Your Medical Device Pitch for Kids!” competition presented by the National Capital Consortium for Pediatric Device Innovation (NCC-PDI). Representing innovations in pediatric technologies that aim to address unmet medical needs for children, these five finalists now have access to a pediatric accelerator program led by MedTech Innovator and will …
05/23/2022
TechNite 2022 Unites Region to Celebrate Year’s Best Technology and Innovation
Roanoke, Va. — The biggest night in tech celebrated the rapidly expanding technology ecosystem and the movers and shakers in the industry on Thursday night at Roanoke-Blacksburg Technology Council’s TechNite 2022 at the Taubman Museum of Art, attracting over 300 statewide and regional leaders. Among the highlights of the evening was the induction of Victor …